Kathryn Deuchars

Director, Ontario Personalized Medicine Network; Senior Manager, Sector Innovation and Programs

Summary

Kathryn Deuchars is a highly accomplished professional with a rich background in genetics, molecular biology, and personalized medicine.
She holds a B.Sc. Honours in Genetics from Western University and a PhD in Molecular Biology from the University of Toronto, showcasing her strong academic foundation.
Kathryn has held various key positions in different organizations, including being a Board Member at Cystic Fibrosis Canada / Fibrose kystique Canada, where she contributes to important decisions regarding the organization's strategies and initiatives.
Her expertise also extends to the field of personalized medicine, as evidenced by her previous role as the Director of the Ontario Personalized Medicine Network and Senior Manager of Sector Innovation and Programs at Ontario Genomics.
With her extensive experience in the biotechnology sector, Kathryn has served as the President and CEO at Light Matter Interaction Inc. (Formerly Attodyne Inc.), demonstrating her leadership skills and business acumen.
In addition, she has also excelled as the Chief Operating Officer at University Medical Discoveries Inc., further showcasing her strong organizational capabilities and strategic vision.
Kathryn Deuchars began her career as a Research Scientist at Allelix BioPharmaceuticals Inc., where she honed her research skills and contributed to the advancements in the field of biopharmaceuticals.